These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Role of pharmacologic or exercise stress echocardiography for the assessment of hemodynamics in valvular heart disease]. Sicari R; La Falce S G Ital Cardiol (Rome); 2011 Oct; 12(10):645-51. PubMed ID: 21947107 [TBL] [Abstract][Full Text] [Related]
8. [Exercise capacity after heart valve replacement]. Horstkotte D; Niehues R; Schulte HD; Strauer BE Z Kardiol; 1994; 83 Suppl 3():111-20. PubMed ID: 7941657 [TBL] [Abstract][Full Text] [Related]
10. Impacts of valve intervention on the Functional REServe of the Heart: The FRESH-valve pilot study. Tan DK; Hothi SS; Macdonald W; Schlosshan D; Tan LB Int J Cardiol; 2015; 187():491-501. PubMed ID: 25846660 [TBL] [Abstract][Full Text] [Related]
11. Symptoms, exercise capacity and exercise hemodynamics: interrelationships and their role in quantification of the valvular lesion. Kraus F; Rudolph W Herz; 1984 Aug; 9(4):187-99. PubMed ID: 6479829 [TBL] [Abstract][Full Text] [Related]
12. Stress echocardiography for evaluation of hemodynamics: valvular heart disease, prosthetic valve function, and pulmonary hypertension. Bach DS Prog Cardiovasc Dis; 1997; 39(6):543-54. PubMed ID: 9166365 [TBL] [Abstract][Full Text] [Related]
13. [The quantitative assessment of the physical work capacity of patients following the surgical correction of heart defects]. Kudriashev VE; Beletskiĭ IuV Ter Arkh; 1990; 62(11):108-10. PubMed ID: 2094972 [No Abstract] [Full Text] [Related]
14. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. Cheitlin MD; Douglas PS; Parmley WW J Am Coll Cardiol; 1994 Oct; 24(4):874-80. PubMed ID: 7930219 [No Abstract] [Full Text] [Related]
15. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. Cheitlin MD; Douglas PS; Parmley WW Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S254-60. PubMed ID: 7934748 [No Abstract] [Full Text] [Related]
16. Exercise recommendations in patients with valvular heart disease. Gati S; Malhotra A; Sharma S Heart; 2019 Jan; 105(2):106-110. PubMed ID: 30262455 [TBL] [Abstract][Full Text] [Related]
17. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). Bonow RO; Carabello B; de Leon AC; Edmunds LH; Fedderly BJ; Freed MD; Gaasch WH; McKay CR; Nishimura RA; O'Gara PT; O'Rourke RA; Rahimtoola SH; Ritchie JL; Cheitlin MD; Eagle KA; Gardner TJ; Garson A; Gibbons RJ; Russell RO; Ryan TJ; Smith SC J Heart Valve Dis; 1998 Nov; 7(6):672-707. PubMed ID: 9870202 [No Abstract] [Full Text] [Related]
18. Invasive Hemodynamics of Valvular Heart Disease. Pighi M; Asgar AW Interv Cardiol Clin; 2017 Jul; 6(3):319-327. PubMed ID: 28600087 [TBL] [Abstract][Full Text] [Related]
20. [When is surgery needed for minimally symptomatic or asymptomatic acquired valvulopathy?]. Acar J; Michel PL; de Gevigney G Presse Med; 2000 Nov; 29(34):1867-75. PubMed ID: 11709821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]